Bupranolol（Cat No.:R016039）is a non-selective beta-adrenergic receptor antagonist (beta-blocker) used primarily for its cardiovascular effects, including the treatment of hypertension, angina pectoris, and certain arrhythmias. It exhibits both β₁- and β₂-receptor blocking activity, reducing heart rate, myocardial contractility, and blood pressure. Bupranolol also has membrane-stabilizing properties and a relatively short half-life, making it suitable for acute interventions. It crosses the blood-brain barrier and may exert central nervous system effects. In research, it is used to study beta-receptor pharmacology, autonomic regulation, and cardiovascular drug responses in both in vitro and in vivo models.